Qiagen NV
QGEN42.085USD
-0.975-2.26%
收盤 04/25, 16:00（美東）報價延遲15分鐘
9.10B總市值
108.81本益比TTM
關於 Qiagen NV 公司
Qiagen NV 是一家總部位於荷蘭的控股公司。該公司致力於提供從樣本到洞察的解決方案，將生物樣本轉化爲分子洞察。其從樣本到洞察解決方案集成了樣本和分析技術、生物信息學和自動化系統。其樣本技術用於從血液或其他液體、組織、植物或其他材料中分離和製備脫氧核糖核酸 (DNA)、核糖核酸 (RNA) 和蛋白質。其分析技術使這些生物分子可見以供分析，例如識別病原體的遺傳信息或腫瘤中的基因突變。其生物信息學解決方案解釋數據以提供可操作的洞察。該公司基於聚合酶鏈反應 (PCR)、下一代測序 (NGS) 和其他技術的自動化平臺將這些技術結合在一起，形成從樣本到洞察的分子檢測工作流程。
公司簡介
公司代碼QGEN
公司名稱Qiagen NV
上市日期Sep 01, 1996
成立日期1996
CEOMr. Thierry Bernard
員工數量5765
證券類型Ordinary Share
年結日Sep 01
公司地址Hulsterweg 82
城市VENLO
上市交易所NYSE Consolidated
國家Netherlands
郵編5912 PL
電話31773556600
網址https://www.qiagen.com/
公司代碼QGEN
上市日期Sep 01, 1996
成立日期1996
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Lawrence A. Rosen
Mr. Lawrence A. Rosen
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
業務USD
名稱
營收
佔比
Consumables and Related Revenues
1.76B
88.98%
Instrumentation
218.00M
11.02%
地區USD
名稱
營收
佔比
United States
942.01M
47.62%
Europe & Middle East & Africa
648.49M
32.78%
Asia, Pacific & Rest of the World
298.15M
15.07%
Other Americas
89.56M
4.53%
業務
地區
業務USD
名稱
營收
佔比
Consumables and Related Revenues
1.76B
88.98%
Instrumentation
218.00M
11.02%
股東統計
更新時間: 4月25日 週五
更新時間: 4月25日 週五
持股股東
股東類型
持股股東
股東統計
佔比
Wellington Management Company, LLP
10.78%
BlackRock Institutional Trust Company, N.A.
8.94%
The Vanguard Group, Inc.
3.95%
Amundi Asset Management, SAS
2.18%
Nuance Investments, LLC
1.86%
Other
72.29%
持股股東
股東統計
佔比
Wellington Management Company, LLP
10.78%
BlackRock Institutional Trust Company, N.A.
8.94%
The Vanguard Group, Inc.
3.95%
Amundi Asset Management, SAS
2.18%
Nuance Investments, LLC
1.86%
Other
72.29%
股東類型
股東統計
佔比
Investment Advisor/Hedge Fund
28.53%
Investment Advisor
28.51%
Hedge Fund
2.60%
Sovereign Wealth Fund
1.88%
Holding Company
1.44%
Research Firm
1.42%
Pension Fund
0.90%
Bank and Trust
0.81%
Individual Investor
0.44%
Other
33.47%
機構持股
更新時間: 1月20日 週一
更新時間: 1月20日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
973
142.86M
66.10%
-56.12M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
2023Q1
1001
160.07M
74.44%
-9.45M
2022Q4
1009
160.10M
74.55%
-10.38M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Wellington Management Company, LLP
23.29M
10.78%
+2.11M
+9.98%
Jan 31, 2025
BlackRock Institutional Trust Company, N.A.
19.32M
8.94%
-13.86K
-0.07%
Mar 04, 2025
The Vanguard Group, Inc.
8.54M
3.95%
+77.90K
+0.92%
Dec 31, 2024
Amundi Asset Management, SAS
4.71M
2.18%
-798.61K
-14.50%
Dec 31, 2024
Nuance Investments, LLC
4.03M
1.86%
-338.28K
-7.74%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
3.96M
1.83%
-111.67K
-2.74%
Dec 31, 2024
Bank of America Corp
3.95M
1.83%
+3.95M
--
May 10, 2024
BlackRock Asset Management Deutschland AG
2.75M
1.27%
+37.88K
+1.40%
Mar 31, 2025
Capital International Investors
2.36M
1.09%
--
--
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月6日 週日
更新時間: 4月6日 週日
機構名稱
佔比
Global X Genomics & Biotechnology ETF
4.14%
Global X Telemedicine & Digital Health ETF
3.49%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.17%
Invesco Biotechnology & Genome ETF
2.41%
VanEck Biotech ETF
1.43%
Franklin Genomic Advancements ETF
1.41%
ROBO Global Healthcare Technology & Innovation ETF
1.37%
WisdomTree BioRevolution Fund
1.16%
iShares Health Innovation Active ETF
0.82%
FlexShares US Quality Low Volatility Index Fund
0.74%
查看更多
Global X Genomics & Biotechnology ETF
佔比4.14%
Global X Telemedicine & Digital Health ETF
佔比3.49%
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比3.17%
Invesco Biotechnology & Genome ETF
佔比2.41%
VanEck Biotech ETF
佔比1.43%
Franklin Genomic Advancements ETF
佔比1.41%
ROBO Global Healthcare Technology & Innovation ETF
佔比1.37%
WisdomTree BioRevolution Fund
佔比1.16%
iShares Health Innovation Active ETF
佔比0.82%
FlexShares US Quality Low Volatility Index Fund
佔比0.74%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
公告日期
類型
比率
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 17, 2025
Merger
36<35
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25
Jan 18, 2024
Merger
25<24.25